CVRx Inc. (CVRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 9201 WEST BROADWAY AVENUE
MINNEAPOLIS, MN 55445
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments90,569106,194142,072
Cash and cash equivalents90,569106,194142,072
Receivables7,5515,5042,560
Inventory, net of allowances, customer advances and progress billings10,9836,9573,880
Inventory10,9836,9573,880
Other undisclosed current assets2,9874,2232,585
Total current assets:112,090122,878151,097
Noncurrent Assets
Operating lease, right-of-use asset1,349334 
Property, plant and equipment1,7631,6981,425
Other noncurrent assets272726
Total noncurrent assets:3,1392,0591,451
TOTAL ASSETS:115,229124,937152,548
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,8648,0885,908
Accounts payable1,8841,719510
Accrued liabilities5,9806,3695,398
Total current liabilities:7,8648,0885,908
Noncurrent Liabilities
Long-term debt and lease obligation29,2226,747 
Long-term debt, excluding current maturities29,2226,747 
Liabilities, other than long-term debt2,196922681
Other liabilities1,036805681
Operating lease, liability1,160117 
Total noncurrent liabilities:31,4187,669681
Total liabilities:39,28215,7576,589
Equity
Equity, attributable to parent75,947109,180145,959
Common stock209207204
Additional paid in capital553,326545,362540,707
Accumulated other comprehensive loss(207)(207)(198)
Accumulated deficit(477,381)(436,182)(394,754)
Total equity:75,947109,180145,959
TOTAL LIABILITIES AND EQUITY:115,229124,937152,548

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
Revenues39,29522,46913,036
Cost of revenue(6,256)(4,999)(3,640)
Gross profit:33,03917,4709,396
Operating expenses(76,142)(59,997)(35,364)
Operating loss:(43,103)(42,527)(25,968)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
3,8501,373(14,800)
Interest and debt expense(1,799)(165)(2,219)
Loss from continuing operations before income taxes:(41,052)(41,319)(42,987)
Income tax expense(147)(109)(91)
Loss from continuing operations:(41,199)(41,428)(43,078)
Loss before gain (loss) on sale of properties:(43,078)
Net loss available to common stockholders, diluted:(41,199)(41,428)(43,078)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
Net loss:(41,199)(41,428)(43,078)
Comprehensive loss:(41,199)(41,428)(43,078)
Other undisclosed comprehensive loss, net of tax, attributable to parent (9)(8)
Comprehensive loss, net of tax, attributable to parent:(41,199)(41,437)(43,086)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: